EURACTIV's Agenda

of all European Affairs Events, conferences, presentations and workshops.

Shaping an ambitious legislative framework for endocrine disruptors: A high-level panel discussion on the gaps between science and legislation

Date

07 Jun 2023 14:00 to 15:30

Address

European Parliament
Room Spinelli 5F385
  Brussels
Belgium

Section

Health & Consumers
Science & Policymaking

Event Description

The European Society of Endocrinology is pleased to invite you for the event “Shaping an ambitious legislative framework for endocrine disruptors: A high-level panel discussion on the gaps between science and legislation” taking place on June 7 between 14:00 and 15:30PM CEST at the European Parliament in room Spinelli 5F385. The panel discussion will be followed by a one-hour networking cocktail at 15:30 to continue the conversation in the multifunctional restaurant salons. The event is organised in association with the Endocrine Society, the European Society for Paediatric Endocrinology and the European Thyroid Association and is kindly hosted by Members of the European Parliament Sirpa Pietikäinen (EPP, Finland) and Martin Hojsík (Renew Europe, Slovakia).

The meeting will bring together a broad variety of stakeholders to discuss the progress and remaining challenges in the area of endocrine disruptors at the EU level. It will present the latest available science and give special attention to vulnerable groups in our society and link these to current debates around CLP, REACH, PFAS and Bisphenols. Special attention will be given to women and children as the impact of endocrine disruptors on these two specific groups has not been sufficiently highlighted in the ongoing EU debate.

The panel discussion, moderated by Sue Saville, will mainly centre around REACH and the difference a timely and ambitious revision could make for European public health. Among many other topics, the panel members will discuss the position of the different EU institutions towards REACH and revisit a recent Petition as well as an Open Letter by ESE and its partners urging the European Commission to publish an ambitious proposal now. Initiatives by patient organisations and civil society in relation to REACH or other topics in the area of endocrine disruptors will also be discussed in more detail.

For more information and to register, please click here.